AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES
Go back to AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES| Amgen Inc (NASDAQ: AMGN) | Delayed: 406.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $406.09 | 52 Week High | $176.85 | |||
| Open | $406.09 | 52 Week Low | $133.64 | |||
| Day High | $406.09 | P/E | 61.16 | |||
| Day Low | $406.09 | EPS | $6.64 | |||
| Volume | 2,327 | |||||

